东财中证沪港深创新药指数发起式A(014128)申购赎回 |
|
|
| 报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
| 2024/3/31 |
63,811,300 |
55,510,600 |
9,531,050 |
17,831,800 |
-8,300,750 |
-13.01% |
| 2023/12/31 |
35,836,200 |
63,811,300 |
57,750,400 |
29,775,200 |
27,975,200 |
78.06% |
| 2023/12/31 |
44,919,400 |
63,811,300 |
30,959,500 |
12,067,600 |
18,891,900 |
42.06% |
| 2023/9/30 |
41,950,200 |
44,919,400 |
7,516,200 |
4,546,970 |
2,969,230 |
7.08% |
| 2023/6/30 |
35,836,200 |
41,950,200 |
19,274,700 |
13,160,700 |
6,114,000 |
17.06% |
| 2023/6/30 |
36,570,100 |
41,950,200 |
12,014,700 |
6,634,620 |
5,380,080 |
14.71% |
| 2023/3/31 |
35,836,200 |
36,570,100 |
7,259,960 |
6,526,030 |
733,930 |
2.05% |
| 2022/12/31 |
36,899,500 |
35,836,200 |
20,813,800 |
21,877,100 |
-1,063,300 |
-2.88% |
| 2022/12/31 |
35,890,900 |
35,836,200 |
4,537,150 |
4,591,930 |
-54,780 |
-0.15% |
| 2022/9/30 |
32,825,300 |
35,890,900 |
6,470,630 |
3,405,030 |
3,065,600 |
9.34% |
| 2022/6/30 |
36,899,500 |
32,825,300 |
9,806,000 |
13,880,100 |
-4,074,100 |
-11.04% |
| 2022/6/30 |
38,576,300 |
32,825,300 |
2,621,360 |
8,372,300 |
-5,750,940 |
-14.91% |
| 2022/3/31 |
36,899,500 |
38,576,300 |
7,184,640 |
5,507,820 |
1,676,820 |
4.54% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。
